Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002
Relationship between acidity of exhaled breath condensate, lung function and airway inflammation in asthmatic children Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007
Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Breath condensate pH in the monitoring of airways inflammation and its response to antibiotic treatment in cystic fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 450s Year: 2007
pH in exhaled breath condensate of patients with inflammatory airway diseases Source: Eur Respir J 2003; 22: Suppl. 45, 240s Year: 2003
Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
pH in expired breath condensate of patients with inflammatory airway diseases Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
Detection of pepsin in sputum and exhaled breath condensate: could it be a useful marker for reflux-related respiratory disease? Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function? Year: 2009
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
Relationship between sputum analysis, methacholine challenge testing and exhaled breath condensate pH in patients with mild-to-moderate well-controlled asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010
Relation of exhaled breath temperature and systemic markers of inflammation and remodelling in stable bronchial asthma Source: International Congress 2016 – Airway biomarkers Year: 2016
Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
Markers of airway diseases in exhaled breath condensate and their clinical value Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013
Association of exhaled breath condensate pH with markers of neutrophilic inflammation in bronchoalveolar lavage in young children with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Adenosine levels in the exhaled breath condensate: a potential surrogate marker of airway inflammation Source: Eur Respir J 2003; 22: 392 Year: 2003
Exhaled nitrite in stable asthmatic children – is it really a good marker for monitoring airway inflammation? Source: Eur Respir J 2006; 28: Suppl. 50, 113s Year: 2006
Exhaled breath condensate pH is a robust and reproducible assay of airway acidity Source: Eur Respir J 2003 Dec 01;22(6):889-894 Year: 2003
Noninvasive biomarkers of airway inflammation and oxidative stress in the exhaled breath of patients with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 371s Year: 2003
Exhaled breath condensate: is this yet of clinical value? Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice Year: 2005